Improving participation in cancer clinical trials at UPMC Hillman Cancer Center
NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer Center
This study is working to make it easier for people with different types of cancer, especially rare ones, to join clinical trials at UPMC Hillman Cancer Center, while also helping new researchers learn how to lead these important studies and ensuring that everyone, including minorities and those from rural areas, has a chance to participate.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11249380 on NIH RePORTER |
What this research studies
This research focuses on enhancing the participation and quality of late-phase clinical trials for various cancers at UPMC Hillman Cancer Center. It aims to improve the processes for activating new trials, particularly for rare cancers and specific genetic subpopulations. The project also emphasizes mentoring junior investigators to develop their skills in conducting clinical trials and taking on leadership roles within the National Clinical Trials Network. By increasing accruals to these trials, the research seeks to ensure diverse populations, including minorities and rural communities, are represented.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals with rare cancers or those belonging to genotypically-defined subpopulations, particularly from minority or rural backgrounds.
Not a fit: Patients with common cancers that are not part of the targeted trials may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for rare cancers and improve access to clinical trials for underrepresented populations.
How similar studies have performed: Previous research has shown success in enhancing clinical trial participation and outcomes through similar collaborative approaches within the National Clinical Trials Network.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Brufsky, Adam M — University of Pittsburgh at Pittsburgh
- Study coordinator: Brufsky, Adam M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.